| ||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 127
-->
Appendix H
Outline of the CCEP Medical Protocol
FORM REQUIREMENTS
At the MTF level, the CCEP record should include all CCEP forms and relevant medical data to the program.
Blank forms included with this guide supersede previous editions of these forms and are intended to be used with the new CCEP.
All individual forms will be complete and legible.
Forms forwarded to NMIMC and maintained in the participant record shall be in the following order:
Phase I completed:
MTF Phase I Diagnosis Form
Patient Questionnaire
Provider-Administered Symptom Questionnaire
Information Release Form
Declination/Completion Form
OCR for page 128
-->
Phase II completed:
RMC Phase II Diagnosis Form
Declination/Completion Form
MEDICAL PROTOCOLS
The CCEP is based upon a thorough clinical evaluation which emphasizes comprehensive and continuous primary care. The local MTF primary care provider maintains responsibility for patient evaluation and care throughout the CCEP process.
Medical Treatment Facility (Phase I)
Phase I will consist of a comprehensive history and medical evaluation with completion of Phase I questionnaires and related forms. The examination, both in content and quality, should parallel an inpatient admission work-up. The Phase I examination will include a complete medical history including: family, occupation, social (including tobacco, alcohol, and drug use), exposure to possible toxic agents, psychosocial condition and review of symptoms. The provider will specifically inquire about the symptoms listed on the CCEP Provider-Administered Patient Questionnaire. A comprehensive medical evaluation, with focused attention to the patients' symptoms and health concerns, should be conducted.
Individuals who, after completing MTF Phase I evaluations, do not have a clearly defined diagnosis which explains their symptoms should be reviewed by the CCEP-designated physician for further evaluation and consultations needed and/or for referral to the RMC.
Phase II level evaluations are performed only after complete clinically indicated evaluations (including appropriate specialty consultations) are conducted at the MTF and the RMC.
Phase I Laboratory Tests
CBC
U/A
SMA-12
OCR for page 129
-->
Regional Medical Center (Phase II)
Phase II evaluations consist of the following laboratory tests, consultations, and as necessary, symptom-specific examinations. Elements of the Phase II evaluation may be accomplished by the local MTF as needed in the comprehensive evaluation of the Phase I patient in order to obtain a definitive diagnosis.
Phase II Laboratory Tests
CBC
Sedimentation rate (ESR)
C-Reactive protein
Rheumatoid factor B12 and folate
ANA Thyroid function tests
Liver function
CPK
Urinalysis
TB skin test (PPD) with controls
Chest X-ray
Hepatitis serology
HIV testing
VDRL
B12 and folate
Thyroid function tests
Phase II Consults
(if not accomplished at MTF level)
Dental: Dental only if participant's annual screening not done
Infectious disease
Psychiatry: With physician-administered instruments:
Structured Clinical Interview for DSMIII-R
(SCID) (delete modules for mania and psychosis)
Clinician-Administered PTSD Scale (CAPS)
Neuropsychological Testing: Only as indicated by psychiatry consult
SYMPTOM-SPECIFIC EXAMINATIONS
The RMC CCEP physician ensures that Phase II patients with the following undiagnosed symptoms receive the tests and consultations listed below.
OCR for page 130
-->
Diarrhea
Abdominal
Headache
GI consult
Stool for O and P
Stool leukocytes
Stool culture
Stool culture
Stool volume
Colonscopy with
biopsies
EGD with biopsies and
aspiration
Muscle Aches/ Numbness
EMG/NCV
Chronic Fatigue
Polysomnography and MSLT
Chronic Cough/SOB
Pulmonary consult
Pulmonary function
Tests with exercise and
ABG
Methacholine challenge
If PFTs are normal,
consider broncho
scopy with biopsy/ lavage
GI consult
EGD with biopsy/ aspiration
Colonscopy with biopsy
Abdominal ultrasound
UGI series with small
bowel FT
Abdominal CT scan
Memory Loss
(Only if verified by psych evaluation)
MRI-head
Lumbar puncture
Neuro consult
Neuro psych testing
Chest Pain/ Palpitations
ECG
Exercise stress test
Holter monitor
MRI-head
LP (glucose protein, cell count, VDRL, oligoclonal myelin, basic
protein, pressure)
Neuro consult
Vertigo/Tinnitus
Audiogram
ENG
BAER
Skin Rash
Dermatology consult
Consider biopsy
Reproductive Concerns
Urology consult
GYN consult
Representative terms from entire chapter:
rmc phase